Literature DB >> 8228342

Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine.

R Abraham1, P Minor, G Dunn, J F Modlin, P L Ogra.   

Abstract

Fecal shedding of virulent revertant polioviruses was examined in isolates from infants previously immunized with > or = 1 dose of orally administered live attenuated polio vaccine (OPV) alone, enhanced-potency inactivated polio vaccine (EIPV) alone, or a combination of both. After administration of OPV alone, vaccine poliovirus serotypes were recovered in feces within 1 week and for as long as 31-60 days in 30%-80% of subjects after 1 or 2 doses and in 30%-50% after immunization with > or = 3 doses. No revertant poliovirus shedding was observed after OPV challenge in subjects immunized previously with > or = 3 doses of OPV. However, fecal shedding of revertant poliovirus after OPV challenge was observed in 50%-100% of subjects previously immunized with > or = 3 doses of the EIPV. These findings suggest that prior immunization with EIPV does not prevent fecal shedding of revertant polioviruses after subsequent reexposure to OPV.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228342     DOI: 10.1093/infdis/168.5.1105

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.

Authors:  Evaggelos Dedepsidis; Zaharoula Kyriakopoulou; Vaia Pliaka; Christine Kottaridi; Eugenia Bolanaki; Stamatina Levidiotou-Stefanou; Dimitri Komiotis; Panayotis Markoulatos
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

2.  Direct detection of Sabin poliovirus vaccine strains in stool specimens of first-dose vaccinees by a sensitive reverse transcription-PCR method.

Authors:  D A Buonagurio; J W Coleman; S A Patibandla; B S Prabhakar; J M Tatem
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

3.  Expression of an antigenic adenovirus epitope in a group B coxsackievirus.

Authors:  K Höfling; S Tracy; N Chapman; K S Kim; J Smith Leser
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.

Authors:  Michael Famulare; Stewart Chang; Jane Iber; Kun Zhao; Johnson A Adeniji; David Bukbuk; Marycelin Baba; Matthew Behrend; Cara C Burns; M Steven Oberste
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

5.  Genomic analysis of vaccine-derived poliovirus strains in stool specimens by combination of full-length PCR and oligonucleotide microarray hybridization.

Authors:  Majid Laassri; Eugenia Dragunsky; Joan Enterline; Tatiana Eremeeva; Olga Ivanova; Kathleen Lottenbach; Robert Belshe; Konstantin Chumakov
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel.

Authors:  L M Shulman; Y Manor; R Handsher; F Delpeyroux; M J McDonough; T Halmut; I Silberstein; J Alfandari; J Quay; T Fisher; J Robinov; O M Kew; R Crainic; E Mendelson
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

7.  Microarrays for genotyping human group a rotavirus by multiplex capture and type-specific primer extension.

Authors:  Lovisa Lovmar; Caroline Fock; Felix Espinoza; Filemon Bucardo; Ann-Christine Syvänen; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.

Authors:  Jiawei Xu; Qing Wang; Shanshan Kuang; Rong Rong; Yuanyuan Zhang; Xiaojuan Fu; Wenge Tang
Journal:  Hum Vaccin Immunother       Date:  2021-03-24       Impact factor: 3.452

Review 9.  Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Authors:  P L Lopalco
Journal:  Epidemiol Infect       Date:  2016-11-21       Impact factor: 4.434

10.  Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.

Authors:  Charles E McGee; Konstantin A Tsetsarkin; Bruno Guy; Jean Lang; Kenneth Plante; Dana L Vanlandingham; Stephen Higgs
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.